The Maudsley Deprescribing Guidelines (häftad, eng)
The Maudsley Deprescribing Guidelines (häftad, eng)
Gästpris:
Ditt medlemspris:
533 kr
619 kr
Kampanjpris! (-6%)
Kampanjpris! (-19%)
- Inköpspriser för medlemmar (Logga in)
- Frakt från 0 kr
- 14 dagars öppet köp
Frågor? Starta chatt
The Maudsley® Deprescribing Guidelines Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more.
Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so.
The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment. This evidence-based handbook provides an overview of principles to be used in deprescribing.
This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts). Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released).
The Maudsley Deprescribing Guidelines covers topics such as: Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugsBarriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation processDistinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treatThe difference between physical dependence and addiction/substance use disorderExplanation of why and how to implement hyperbolic tapering in clinical practiceSpecific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approachesStep-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individualTroubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse.
Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.
Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so.
The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment. This evidence-based handbook provides an overview of principles to be used in deprescribing.
This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts). Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released).
The Maudsley Deprescribing Guidelines covers topics such as: Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugsBarriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation processDistinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treatThe difference between physical dependence and addiction/substance use disorderExplanation of why and how to implement hyperbolic tapering in clinical practiceSpecific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approachesStep-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individualTroubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse.
Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.
| Format | Häftad |
| Omfång | 592 sidor |
| Språk | Engelska |
| Förlag | John Wiley and Sons Ltd |
| Utgivningsdatum | 2024-02-15 |
| ISBN | 9781119822981 |
Artikelnummer
2977183
EAN
9781119822981
Leverans:
Denna produkt skickas från oss inom 6 - 7 vardagar. I kassan väljer du om du vill få leverans med Budbee, Airmee, Best Transport, Early Bird, Postnord eller DB Schenker. Vissa speditörer har vikt- eller storleksbegränsningar och kan av den anledningen saknas som alternativ i kassan om du handlar många eller väldigt stora produkter.Fri retur:
För medlemmar gäller fri retur och 14 dagars full returrätt från den dagen du tar emot din leverans. För övriga kostar retur från 49 kr.Undantag för retur- och ångerrätt:
Dessa är exempel på varor som inte omfattas av retur- eller ångerrätt. Observera att det kan finnas andra undantag som inte listas här.- Använda, skadade och/eller inkompletta produkter
- Dagligvaror (livsmedel, läkemedel, nikotinprodukter)
- Hygienartiklar & kroppsnära produkter (rakapparater, in ear-hörlurar, aktivitetsklockor)
- Intimprodukter (menskoppar, kondomer och glidmedel)
- Kosmetikprodukter (inkl. hår- och hudvårdsprodukter, parfymer, etc.)
- Underkläder (inkl. badkläder, underställ och strumpor)
- Ljud- & bildupptagningar, spel/program (om förseglingen brutits eller licensnyckeln erhållits.)
- Teknikprodukter om försegling brutits eller programvara har installerats (mobiltelefoner, surfplattor, laptops, etc.)
- Gratisprodukter
Om du är osäker på om en produkt omfattas av ångerrätt kan du alltid kontakta vår kundtjänst på info@buyersclub.se, så hjälper vi dig gärna!
Leveranser:
